Exclusive Enteral Nutrition Versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease

Gastroenterology Research and Practice - United States
doi 10.1155/2017/6595048
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Effects of the Exclusive Enteral Nutrition on the Microbiota Profile of Patients With Crohn’s Disease: A Systematic Review

Nutrients
NutritionFood ScienceDietetics
2017English

The Efficacy of Total Enteral Nutrition in Inducing Remission and Improving Nutritional Status in Children With Moderate to Severe Crohn’s Disease

Przeglad Gastroenterologiczny
Gastroenterology
2013English

Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Digestive Diseases and Sciences
PhysiologyGastroenterology
2018English

Exclusive Enteral Nutrition and Mucosal Healing in Newly Diagnosed Children With Crohn’s Disease: Comparison of Clinical Parameters, Biomarkers and Mucosal Microbiome Between Responders and Non-Responders

English

Enteral Nutrition in the Management of Pediatric Intestinal Failure

Journal of Pediatrics
Child HealthPediatricsPerinatology
2014English

Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Infliximab Treatment Time and the Mucosal Healing Effect in Pediatric Patients With Severe Crohn’s Disease – Own Experience

Przeglad Gastroenterologiczny
Gastroenterology
2012English

Individualized Treatment With Infliximab Therapy in Children With Crohn’s Disease Support Shorter Time Intervals Between Infusions

Journal of Drug Assessment
2012English

Exclusive Enteral Nutrition Provides an Effective Bridge to Safer Interval Elective Surgery for Adults With Crohn's Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy